The UK commercial life sciences sector is expected to enter 2026 with a softer hiring outlook as firms shift from rapid expansion towards cost control and operational efficiency. Commercial vacancies are forecast to decline 1.4% year-on-year following several years of strong growth linked to GLP-1 launches and broader pharmaceutical expansion.
Britain’s fintech labour market continues to expand despite an increasingly unsettled macroeconomic backdrop. Vacancies are forecast to rise by close to 14% in 2026, following a sharper 28% increase the previous year. London remains overwhelmingly dominant. Hiring in the capital is projected to grow by just over 14%, lifting its share of national fintech vacancies from nearly 67% in 2024 to around 71% this year. Early-month data suggests the momentum is not merely seasonal.
Professional hiring activity across the South East is expected to strengthen again in 2026, although growth is becoming increasingly concentrated around specific functions. Rather than expanding headcount broadly, many employers are prioritising digital capability, engineering delivery and revenue generation, while more cyclical sectors continue to soften.
The UK tax labour market is entering a correction phase after a sharp expansion in 2025. Vacancies rose by around 19% last year, but are now projected to decline by roughly 10% in 2026, pointing to stabilisation rather than contraction.
Hiring conditions in the South West have improved at the start of 2026, though the pace remains controlled. Vacancies rose by 7.9% compared to the previous quarter, returning close to levels seen at the start of 2025. This suggests demand has stabilised, with employers resuming hiring where required rather than expanding broadly
Engineering hiring across the UK pharmaceuticals sector is entering a period of adjustment, with vacancies forecast to fall by 31.5% in 2026 following strong growth of 19.2% in 2025. The shift reflects a move away from expansion-led hiring towards a more efficiency-driven approach, as organisations respond to cost pressures and evolving operating models.
